Cargando…
Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model
BACKGROUND: Cervical cancer has been shown to be highly associated with human papillomavirus (HPV) infection. The viral oncogenes E6 and E7 are constantly expressed by the tumor cells and are therefore potent targets for therapeutic genetic vaccination. In the present study, it was investigated the...
Autores principales: | Fazeli, Maryam, Soleimanjahi, Hoorieh, Dadashzadeh, Simin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Research Center, Shahid Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360347/ https://www.ncbi.nlm.nih.gov/pubmed/25821567 |
Ejemplares similares
-
Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021) -
Histopathological characteristics and HPV status in cervical biopsy specimens diagnosed as flat condyloma
por: Nategh, Fatemeh, et al.
Publicado: (2023) -
Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer
por: Karimi, Hesam, et al.
Publicado: (2020) -
Construction of Recombinant Bacmid Containing M2e-Ctxb and Producing the Fusion Protein in Insect Cell Lines
por: Mirzaei, Nima, et al.
Publicado: (2014) -
Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)